Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02331524 · ClinicalTrials.gov registry record · NA

Interventions to Improve Daily Activity in Heart Failure

A NA study of Heart Failure, sponsored by Grand Valley State University.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT02331524: Completed NA study of Heart Failure, sponsored by Grand Valley State University.

NCT02331524 is a NA study of Heart Failure that has completed, run by Grand Valley State University. The registered enrollment target is 16 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02331524, a NA study of Heart Failure, has completed, sponsored by Grand Valley State University.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

There are few studies that demonstrate how to best improve daily activity in people with heart failure (HF). Exercise alone has been shown to be ineffective, but other techniques such as daily activity feedback with encouragement or health coaching may be helpful. This research study will investigate two different treatment approaches for improving daily activity: 1) daily activity feedback and encouragement, and 2) health coaching with an individualized home exercise program. Both treatment approaches are hypothesized to result in improved daily activity compared to a control group.

Conditions Studied

Interventions

  • BEHAVIORAL Activity Feedback and Encouragement
  • OTHER Health Coaching/Home Exercise

Study Locations (1)

Michigan

  • Spectrum Health Heart and Lung Specialized Care Clinic - Grand Rapids

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2014-10
Est. Completion 2016-07
Phase NA
Grand Valley State University

11 total trials

What the finished NCT02331524 record still lists

NCT02331524 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Activity Feedback and Encouragement is the first listed.

NCT02331524 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02331524 about?

NCT02331524 is a clinical study titled "Interventions to Improve Daily Activity in Heart Failure". There are few studies that demonstrate how to best improve daily activity in people with heart failure (HF). Exercise alone has been shown to be ineffective, but other techniques such as daily activity feedback with encouragement or health coaching may be helpful. This research study will investigat...

What is the current status of trial NCT02331524?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2014-10. Estimated completion is 2016-07.

What conditions does trial NCT02331524 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT02331524?

The interventions under investigation include: Activity Feedback and Encouragement (BEHAVIORAL), Health Coaching/Home Exercise (OTHER).

Who is sponsoring clinical trial NCT02331524?

This trial is sponsored by Grand Valley State University, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02331524 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02331524's enrollment target sits among peer trials

16 369th of 397 higher than 27 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02331524, the US trial registry maintained by the National Library of Medicine. NCT02331524 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.